Sakane N. Diabetes prevention in the real world: insights from the JDPP and J-DOIT1. J Gen Fam Med. 2017;18(6):325–30.

Article  PubMed  PubMed Central  Google Scholar 

Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y. From pre-diabetes to diabetes: diagnosis, treatments and translational research. Med (Kaunas). 2019;55(9):546.

Google Scholar 

Ahlqvist E, Storm P, Käräjämäki A, Martinell M, Dorkhan M, Carlsson A, et al. Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. 2018;6(5):361–9.

Article  PubMed  Google Scholar 

Tanabe H, Sato M, Miyake A, Shimajiri Y, Ojima T, Narita A, et al. Machine learning-based reproducible prediction of type 2 diabetes subtypes. Diabetologia. 2024;67(11):2446–2458.

Tanabe H, Hirai H, Saito H, Tanaka K, Masuzaki H, Kazama JJ, et al. Detecting sarcopenia risk by diabetes clustering: a Japanese prospective cohort study. J Clin Endocrinol Metab. 2022;107(10):2729–36.

Article  PubMed  Google Scholar 

Taurbekova B, Sarsenov R, Yaqoob MM, Atageldiyeva K, Semenova Y, Fazli S, et al. Cluster analysis in diabetes research: a systematic review enhanced by a cross-sectional study. J Clin Med. 2025;14(10):3588.

Article  CAS  PubMed  PubMed Central  Google Scholar 

You L, Ferrat LA, Oram RA, Parikh HM, Steck AK, Krischer J, et al. Type 1 diabetes risk phenotypes using cluster analysis. Diabetologia. 2024;67(11):2507–2517.

Somolinos-Simón FJ, García-Sáez G, Tapia-Galisteo J, Corcoy R, Hernando ME. Cluster analysis of adult individuals with type 1 diabetes: Treatment pathways and complications over a five-year follow-up period. Diabetes Res Clin Pract. 2024;215:111803.

Takeshita S, Nishioka Y, Tamaki Y, Kamitani F, Mohri T, Nakajima H, et al. Novel subgroups of obesity and their association with outcomes: A data-driven cluster analysis. BMC Public Health. 2024;24(1):124.

Sakane N, Kotani K, Takahashi K, Sano Y, Tsuzaki K, Okazaki K, et al. Effects of telephone-delivered lifestyle support on the development of diabetes in participants at high risk of type 2 diabetes: J-DOIT1, a pragmatic cluster randomised trial. BMJ Open. 2015;5(8):e007316.

Article  PubMed  PubMed Central  Google Scholar 

Milligan GW, Cooper MC. An examination of procedures for determining the number of clusters in a data set. Psychometrika. 1985;50:159–79.

Article  Google Scholar 

Yabe D, Seino Y, Fukushima M, Seino S. β-cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians. Curr Diab Rep. 2015;15(6):602.

Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343–1350.

Allaire BT, Tjaden AH, Venditti EM, Apolzan JW, Dabelea D, Delahanty LM, et al. Diet quality, weight loss, and diabetes incidence in the Diabetes Prevention Program. BMC Nutr. 2020;6(1):74.

Kobayashi E, Linden-Santangeli NJ, Chan N, et al. Longitudinal metabolic trajectories in Diabetes Prevention Program participants reveal subgroups with varying micro- and macrovascular complication risks. Diabetes Care. 2025.

Zheng R, Xu Y, Li M, Gao Z, Wang G, Hou X, et al. Data-driven subgroups of prediabetes and the associations with outcomes in Chinese adults. Cell Rep Med. 2023;4(3):100958.

Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840–846.

Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860–7.

Article  CAS  PubMed  Google Scholar 

Sattar N, Scherbakova O, Ford I, O’Reilly DS, Stanley A, Forrest E, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors. Diabetes. 2004;53(11):2855–2860.

Fraser A, Harris R, Sattar N, Ebrahim S, Davey Smith G, Lawlor DA. Alanine aminotransferase, gamma-glutamyltransferase, and incident diabetes. Diabetes Care. 2009;32(4):741–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Katsi V, Argyriou N, Fragoulis C, Tsioufis K. The role of non-HDL cholesterol and apolipoprotein B in cardiovascular disease: A comprehensive review. J Cardiovasc Dev Dis. 2025;12(7):256.

Raja V, Aguiar C, Alsayed N, Chibber YS, ElBadawi H, Ezhov M, et al. Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook. Atherosclerosis. 2023;383:117312.

Esmaeili S, Shafiee A, Ataie-Jafari A, Semnani K, Goodarzi S, Mahdavi-Gorabi A, et al. Non-HDL-C and non-HDL-C/HDL-C ratio as predictors of hepatic steatosis: a systematic review and meta-analysis. J Diabetes Metab Disord. 2025;24(2):214.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Deberneh HM, Kim I. Prediction of type 2 diabetes based on machine learning algorithm. Int J Environ Res Public Health. 2021;18(6):3317.

Article  PubMed  PubMed Central  Google Scholar 

Aoki J, Khalid O, Kaya C, Nagymanyoki Z, Hussong J, Salama ME. Progression from prediabetes to diabetes in a diverse US population: a machine learning model. Diabetes Technol Ther. 2024;26(10):748–753.

Agrawal R. Prediabetes: to be treated or not? J Assoc Physicians India. 2025;73(10):96–8.

PubMed  Google Scholar